60229-58-5

Upstream product

• 36455-21-7 3-benzyloxy-4-methoxyphenylethylamine 
• 5470-14-4 (6-bromobenzo[1,3]dioxol-5-yl)acetic acid 
• 60229-56-3 3-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(3,4-dimethoxyphenethyl)ethanamide 
• 64387-96-8 6-benzyloxy-1-(6-bromo-benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-3,4-dihydro-isoquinoline 

Downstream Products

• 89045-86-3 6-benzyloxy-1-(6-bromo-benzo[1,3]dioxol-5-ylmethyl)-2-formyl-7-methoxy-1,2,3,4-tetrahydro-isoquinoline 
• 60229-59-6 6-benzyloxy-1-(6-bromo-benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinoline 
• 1340566-86-0 (+/-)-2-(benzyloxy)-N-Boc-nor-isodomesticine 
• 1340566-56-4 (+/-)-2-(benzyloxy)isodomesticine 
• 1340566-84-8 tert-butyl-6-(benzyloxy)-1-((6-bromobenzo[d][1,3]dioxol-5-yl)methyl)-7-methoxy-3,4-dihydroisoquinoline-2(1H)-carboxylate 

Relevant academic research and scientific papers

New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine

A series of C1, C2, C3 and N6 analogs of nantenine (2) was synthesized and evaluated in 5-HT2A and α1A receptor functional assays. Alkyl substitution of the C1 and N6 methyl groups of nantenine provided selective 5-HT2A an